Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements

Part of paid clinical trials in East Lansing, Michigan.

Sponsor
Michigan State University
Study ID
NCT07599696
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Behavioral speech strategies + speech amplification — BEHAVIORAL
    Behavioral speech strategies + speech amplification

Study Details

The proposed research aims to investigate the use of speech amplification devices as a potential treatment option for people with Parkinson's disease and related disorders who exhibit hypophonia, a voice disorder that affects over half of those with Parkinson's disease. By characterizing the acoustic and perceptual effects of speech amplification and identifying ways to optimize outcomes through talker- and device-specific enhancements, this project seeks to develop personalized, evidence-based treatment options for hypophonia. The current proposal will move this effort forward by systematically eliciting and modifying speech amplification device output that leverage both behavioral and technological approaches.

Key Dates

Start date
Mar 1, 2024
Status verified
May 2026
Primary completion
Dec 31, 2027
Completion
May 31, 2028

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Speech Study
    Single arm study: All speech conditions are administered.

Primary Outcome Measure

Speech intensity [ Time Frame: Day 1 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Michigan State UniversityEast LansingMichigan48823
Thea Knowles, PhD
[email protected]
517-353-6401
Thea Knowles, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in East Lansing, MI

By condition
Parkinson's disease
By specialty
NeurologyBrain disorders
By research site
Michigan State University· East Lansing, MI

Related Studies